Etoposide
Etoposide Injection USP
Approved
Approval ID
157d4e0f-806d-4011-9dec-97e2449e507b
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Jun 20, 2018
Manufacturers
FDA
BluePoint Laboratories
DUNS: 985523874
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Etoposide
PRODUCT DETAILS
NDC Product Code68001-265
Application NumberANDA074513
Marketing CategoryC73584
Route of AdministrationINTRAVENOUS
Effective DateJune 20, 2018
Generic NameEtoposide
INGREDIENTS (6)
ALCOHOLInactive
Quantity: 0.305 mL in 1 mL
Code: 3K9958V90M
Classification: IACT
ANHYDROUS CITRIC ACIDInactive
Quantity: 2 mg in 1 mL
Code: XF417D3PSL
Classification: IACT
ETOPOSIDEActive
Quantity: 20 mg in 1 mL
Code: 6PLQ3CP4P3
Classification: ACTIB
BENZYL ALCOHOLInactive
Quantity: 30 mg in 1 mL
Code: LKG8494WBH
Classification: IACT
POLYSORBATE 80Inactive
Quantity: 80 mg in 1 mL
Code: 6OZP39ZG8H
Classification: IACT
POLYETHYLENE GLYCOL 300Inactive
Quantity: 650 mg in 1 mL
Code: 5655G9Y8AQ
Classification: IACT